Opposing and uncoupling effects of mTOR and S6K1 in the regulation of endothelial tissue factor expression

FEBS Letters

Volumn 584, Issue 1, 2010, Pages 135-140

  Ming, Xiu Fen ^a   Rajapakse, Angana Gupta ^a   Carvas, João Miguel ^a   Ruffieux, Jean ^a   Yang, Zhihong ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Endothelial cell; mTOR; S6K1; Thrombin; Tissue factor; TNF

Indexed keywords

ADENOVIRUS VECTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; RAPAMYCIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; S6 KINASE; S6 KINASE 1; THROMBIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; UMBILICAL VEIN; VIRUS RECOMBINANT;

ADENOVIRIDAE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE KNOCKDOWN TECHNIQUES; HUMANS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASES; RHOA GTP-BINDING PROTEIN; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA INTERFERENCE; THROMBOPLASTIN;

MAMMALIA;

EID: 71549115417     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.11.030     Document Type: Article

References (17)

1. Moons A.H., Levi M., and Peters R.J. Tissue factor and coronary artery disease. Cardiovasc. Res. 53 (2002) 313-325
2. Eto M., Kozai T., Cosentino F., Joch H., and Luscher T.F. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 105 (2002) 1756-1759
3. Viswambharan H., Ming X.F., Zhu S., Hubsch A., Lerch P., Vergeres G., Rusconi S., and Yang Z. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase. Circ. Res. 94 (2004) 918-925
4. Ishibashi T., Sakamoto T., Ohkawara H., Nagata K., Sugimoto K., Sakurada S., Sugimoto N., Watanabe A., Yokoyama K., Sakamoto N., Kurabayashi M., Takuwa Y., and Maruyama Y. Integral role of RhoA activation in monocyte adhesion-triggered tissue factor expression in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 681-687
5. Guba M., Yezhelyev M., Eichhorn M.E., Schmid G., Ischenko I., Papyan A., Graeb C., Seeliger H., Geissler E.K., Jauch K.W., and Bruns C.J. Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF. Blood 105 (2005) 4463-4469
6. Zhu S., Viswambharan H., Gajanayake T., Ming X.F., and Yang Z. Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells. BMC. Cardiovasc. Disord. 5 (2005) 22
7. Steffel J., Latini R.A., Akhmedov A., Zimmermann D., Zimmerling P., Luscher T.F., and Tanner F.C. Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design. Circulation 112 (2005) 2002-2011
8. Luscher T.F., Steffel J., Eberli F.R., Joner M., Nakazawa G., Tanner F.C., and Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115 (2007) 1051-1058
9. Schmelzle T., and Hall M.N. TOR, a central controller of cell growth. Cell 103 (2000) 253-262
10. Burnett P.E., Barrow R.K., Cohen N.A., Snyder S.H., and Sabatini D.M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. USA 95 (1998) 1432-1437
11. Pullen N., Dennis P.B., Andjelkovic M., Dufner A., Kozma S.C., Hemmings B.A., and Thomas G. Phosphorylation and activation of p70s6k by PDK1. Science 279 (1998) 707-710
12. Fingar D.C., Salama S., Tsou C., Harlow E., and Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16 (2002) 1472-1487
13. Ohanna M., Sobering A.K., Lapointe T., Lorenzo L., Praud C., Petroulakis E., Sonenberg N., Kelly P.A., Sotiropoulos A., and Pende M. Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat. Cell Biol. 7 (2005) 286-294
14. Ming X.F., Rajapakse A.G., Carvas J.M., Ruffieux J., and Yang Z. Inhibition of S6K1 accounts partially for the anti-inflammatory effects of the arginase inhibitor L-norvaline. BMC Cardiovasc. Disord. 9 (2009) 12
15. Ming X.F., Viswambharan H., Barandier C., Ruffieux J., Kaibuchi K., Rusconi S., and Yang Z. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol. Cell Biol. 22 (2002) 8467-8477
16. Liu L., Li F., Cardelli J.A., Martin K.A., Blenis J., and Huang S. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Oncogene 25 (2006) 7029-7040
17. Brown K., Gerstberger S., Carlson L., Franzoso G., and Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267 (1995) 1485-1488